Shares of Vanda Pharmaceuticals (VNDA) rise 2.36% premarket and look set to add to what has...

|About: Vanda Pharmaceuticals Inc. (VNDA)|By:, SA News Editor

Shares of Vanda Pharmaceuticals (VNDA) rise 2.36% premarket and look set to add to what has become quite a rally. The stock is up 109% over the past month, gathering momentum from analyst praise (I, II), positive commentary from the Tech Council of Maryland, and an NDA application for Tasimelteon. The company will present at the Jefferies Global Healthcare Conference tomorrow at 2:30.